AP
Appili Therapeutics Inc
APLIF · OTC
$0.01 +0.00% (+$0.00)
1M -8.59%
Market Cap $1.81M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
11.1% upside
Trenutna cena
$0.009
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica APLIF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
37 /100
Fair P/S 4.76x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 9.85%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 1,548.80%
Gross margin 99.32%
FCF margin 347.84%
Quality
62 /100
Average Asset turnover 0.29x
ROIC 105.02%
ROA 361.55%
Debt
0 /100
High Int. coverage -5.88x
Current ratio 0.07x
Debt/Assets N/A
Stability
20 /100
Unstable EPS volatility 62.80%
Beta -0.21x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o APLIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Don Cilla
Employees
7
Headquarters
Halifax
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report